PDF (Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB | |
PDF (Supplemental material)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
91kB |
Item Type: | Article |
---|---|
Title: | MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors |
Creators Name: | Leisegang, M., Wilde, S., Spranger, S., Milosevic, S., Frankenberger, B., Uckert, W. and Schendel, D.J. |
Abstract: | The apoptosis inhibitor protein survivin is overexpressed in many tumors, making it a candidate target molecule for various forms of immunotherapy. To explore survivin as a target antigen for adoptive T cell therapy using lymphocytes expressing survivin-specific transgenic T cell receptors (Tg-TCRs), we isolated HLA-A2-allorestricted survivin-specific T cells with high functional avidity. Lymphocytes expressing Tg-TCRs were derived from these T cells and specifically recognized HLA-A2+ survivin+ tumor cells. Surprisingly, HLA-A2+ but not HLA-A2- lymphocytes expressing Tg-TCRs underwent extensive apoptosis over time. This demise was caused by HLA-A2-restricted fratricide that occurred due to survivin expression in lymphocytes, which created ligands for Tg-TCR recognition. Therefore, survivin-specific TCR gene therapy would be limited to application in HLA-A2-mismatched stem cell transplantation. We also noted that lymphocytes that expressed survivin-specific Tg-TCRs killed T cell clones of various specificities derived from HLA-A2+ but not HLA-A2- donors. These results raise a general question regarding the development of cancer vaccines that target proteins that are also expressed in activated lymphocytes, since induction of high-avidity T cells that expand in lymph nodes following vaccination or later accumulate at tumor sites might limit themselves by self-MHC-restricted fratricide while at the same time inadvertently eliminating neighboring T cells of other specificities. |
Keywords: | Cell Death, Cell Line, HLA-A2 Antigen, Lymphocytes, Major Histocompatibility Complex, Microtubule-Associated Proteins, T-Cell Antigen Receptors, T-Lymphocytes, Transgenes, Animals |
Source: | Journal of Clinical Investigation |
ISSN: | 0021-9738 |
Publisher: | American Society for Clinical Investigation |
Volume: | 120 |
Number: | 11 |
Page Range: | 3869-3877 |
Date: | 1 November 2010 |
Official Publication: | https://doi.org/10.1172/JCI43437 |
PubMed: | View item in PubMed |
Repository Staff Only: item control page